Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 55450-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#55450-1-AP, RRID:AB_11182706
- Product name
- CXCR1 antibody
- Antibody type
- Polyclonal
- Description
- CXCR1 antibody (Cat. #55450-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references CXCR1 drives the pathogenesis of EAE and ARDS via boosting dendritic cells-dependent inflammation.
Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulation.
Targeting CXCR1 alleviates hyperoxia-induced lung injury through promoting glutamine metabolism.
Oral Intervention of Narirutin Ameliorates the Allergic Response of Ovalbumin Allergy.
IL-8 exacerbates CCl(4)-induced liver fibrosis in human IL-8-expressing mice via the PI3K/Akt/HIF-1α pathway.
IL-8 exacerbates alcohol-induced fatty liver disease via the Akt/HIF-1α pathway in human IL-8-expressing mice.
Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling.
The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
Zhuang W, Zhou J, Zhong L, Lv J, Zhong X, Liu G, Xie L, Wang C, Saimaier K, Han S, Shi C, Hua Q, Zhang R, Xie X, Du C
Cell death & disease 2023 Sep 14;14(9):608
Cell death & disease 2023 Sep 14;14(9):608
Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulation.
Tada A, Minami T, Kitai H, Higashiguchi Y, Tokuda M, Higashiyama T, Negi Y, Horio D, Nakajima Y, Otsuki T, Mikami K, Takahashi R, Nakamura A, Kitajima K, Ohmuraya M, Kuribayashi K, Kijima T
Lung cancer (Amsterdam, Netherlands) 2023 Jun;180:107219
Lung cancer (Amsterdam, Netherlands) 2023 Jun;180:107219
Targeting CXCR1 alleviates hyperoxia-induced lung injury through promoting glutamine metabolism.
Qin H, Zhuang W, Liu X, Wu J, Li S, Wang Y, Liu X, Chen C, Zhang H
Cell reports 2023 Jul 25;42(7):112745
Cell reports 2023 Jul 25;42(7):112745
Oral Intervention of Narirutin Ameliorates the Allergic Response of Ovalbumin Allergy.
Shi X, Zhao L, Niu L, Yan Y, Chen Q, Jin Y, Li X
Journal of agricultural and food chemistry 2022 Oct 19;70(41):13313-13326
Journal of agricultural and food chemistry 2022 Oct 19;70(41):13313-13326
IL-8 exacerbates CCl(4)-induced liver fibrosis in human IL-8-expressing mice via the PI3K/Akt/HIF-1α pathway.
Ma Y, Bao Y, Wu L, Ke Y, Tan L, Ren H, Song J, Zhang Q, Jin Y
Molecular immunology 2022 Dec;152:111-122
Molecular immunology 2022 Dec;152:111-122
IL-8 exacerbates alcohol-induced fatty liver disease via the Akt/HIF-1α pathway in human IL-8-expressing mice.
Wang Z, Li B, Jiang H, Ma Y, Bao Y, Zhu X, Xia H, Jin Y
Cytokine 2021 Feb;138:155402
Cytokine 2021 Feb;138:155402
Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling.
Zhang Y, Zou B, Tan Y, Su J, Wang Y, Xu J, Tao L, Zhou H, Liu L, Li X
Pharmacological research 2019 Apr;142:140-150
Pharmacological research 2019 Apr;142:140-150
The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
Mao W, Peters HL, Sutton MN, Orozco AF, Pang L, Yang H, Lu Z, Bast RC Jr
Cancer 2019 Apr 15;125(8):1267-1280
Cancer 2019 Apr 15;125(8):1267-1280
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CXCR1 antibody from Proteintech is a rabbit polyclonal antibody to a peptide of human CXCR1. This antibody recognizes human, mouse antigen. The CXCR1 antibody has been validated for the following applications: ELISA, WB analysis.